Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an imaging-guided pathway replace the current paradigm for muscle-invasive bladder cancer?
Bryan, Richard T Catto, James W F Jefferson, Kieran P Patel, Prashant James, Nicholas D On Behalf Of The BladderPath Trial Management Group
Bryan, Richard T
Catto, James W F
Jefferson, Kieran P
Patel, Prashant
James, Nicholas D
On Behalf Of The BladderPath Trial Management Group
Citations
Altmetric:
Affiliation
University of Birmingham; University of Sheffield; Sheffield Teaching Hospitals NHS Trust; University Hospital Coventry & Warwickshire; University Hospitals Birmingham NHS Foundation Trust; Institute of Cancer Research; The Royal Marsden NHS Foundation Trust
Other Contributors
Publication date
2021-05-08
Subject
Research Projects
Organizational Units
Journal Issue
Abstract
No abstract available
Citation
Bryan RT, Catto JWF, Jefferson KP, Patel P, James ND, On Behalf Of The BladderPath Trial Management Group. Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an Imaging-guided Pathway Replace the Current Paradigm for Muscle-invasive Bladder Cancer? Eur Urol. 2021 Jul;80(1):18-19. doi: 10.1016/j.eururo.2021.04.034. Epub 2021 May 8.
Type
Correspondence